TECLISTAMAB-CQYV: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
49.5%
Female
50.5%
Male
Age Information
The average age of patients reporting adverse events with TECLISTAMAB-CQYV is 68.9 years.
Geographic Distribution
The majority of adverse event reports for TECLISTAMAB-CQYV originate from US.
Report Summary & Outcomes
1,592
Total Reports
1,592
As Primary/Secondary Suspect
338
Deaths Reported
395
Hospitalizations
60
Life-Threatening
15
Disabilities
Reporting Timeline
First adverse event report: 20201201. Most recent report: 20250924. View full timeline →